Aptus Pharma Schedules Board Meeting on 20th Oct'26 for Half-Year Results
Aptus Pharma Ltd 路 Intimation 路 20 Oct 2026, 5:30 am
Aptus Pharma Schedules Board Meeting on 20th Oct'26 for Half-Year Results Aptus Pharma Limited has scheduled a Board of Directors meeting on 20th Oct'26 to consider, approve, and take on record the company's Unaudited Financial Results and Limited Review Report for the half-year ended 30th Sep'26. Additionally, pursuant to SEBI insider trading regulations, the trading window for dealing in the company's securities has been closed effective 1st Oct'26 and will remain closed until 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Aptus Pharma Ltd
- Outcome of Board Meeting - Allotment of Equity Shares on Preferential Basis under Regulation 30 of SEBI LODR Regulations, 2015 路 12 Nov 2026
- Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting for .... 路 06 Nov 2026
- Receipt of In-Principle Approval for Preferential Issue 路 31 Oct 2026
- Transcript for Earning Call for the Quarter and Half Year ended on September 30, 2026 路 30 Oct 2026
- Audio recording of the Earnings Call dated October 26, 2026 路 27 Oct 2026
- Intimation of Investor Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 23 Oct 2026
- Intimation of Earnings Call for the quarter and half year ended September 30, 2026 路 26 Oct 2026
- Pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company .... 路 21 Oct 2026
